🇺🇸 FDA
Patent

US 7118919

13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

granted A61KA61K51/1206

Quick answer

US patent 7118919 (13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control) held by Isotechnika, Inc. expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Isotechnika, Inc.
Grant date
Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K51/1206